COVID-19 MORTALITY RATES AND CHANGES IN ANTI-DEMENTIA AND PSYCHOTROPIC MEDICATION USE AMONG NURSING HOME RESIDENTS
Alison Rataj, Matthew Alcusky, Brian Ott, Jonggyu Baek, Shiwei Liang, Kate Lapane · 2024
Read COVID-19 MORTALITY RATES AND CHANGES IN ANTI-DEMENTIA AND PSYCHOTROPIC MEDICATION USE AMONG NURSING HOME RESIDENTS by Alison Rataj, Matthew Alcusky, Brian Ott, Jonggyu Baek, Shiwei Liang, Kate Lapane (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11691710.txt.
Description
Alison Rataj and co-authors study United States nursing homes in a 2024 paper on drug use during the COVID-19 pandemic. Homes with heavy death tolls faced staff loss and strict isolation, which could change how often doctors started dementia or mental health drugs. The team surveyed nursing directors across the country in 2022.
Homes with higher peak death rates were less likely to report changes in starting dementia drugs, in either direction. No link appeared for mental health drugs as a group. Homes that saw more behavior problems in residents, though, were far more likely to start such drugs. The authors tie that rise to the strain of isolation during the pandemic.
Catalog record
| CREATOR | Alison Rataj, Matthew Alcusky, Brian Ott, Jonggyu Baek, Shiwei Liang, Kate Lapane |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |